• 17 minutes 41 seconds
    India's Crypto Crackdown: What the ED Raids Mean for Investors

    India taxes cryptocurrency but has yet to establish a comprehensive framework governing its trade and use. Now, Enforcement Directorate investigations into CoinDCX and Delta Exchange have raised fundamental questions about how cryptocurrencies enter India. Meanwhile, crypto futures offer leverage of up to 100 times, and digital assets are quietly finding their way into everyday payments through cards and UPI QR codes.

    Anirban Chowdhury speaks to ET's Sugata Ghosh about the regulatory grey areas, the risks of crypto derivatives, potential tax loopholes and why India's policymakers remain behind the curve. Could the latest investigations threaten the future of crypto trading in India?

    See omnystudio.com/listener for privacy information.

    20 November 2026, 12:15 am
  • 24 minutes 55 seconds
    Inflation at 6%: Is the RBI Losing Control?

    India's inflation has crossed the RBI's 6% tolerance ceiling. Food prices are climbing, household incomes are under pressure, and the central bank's response is under scrutiny. Has the RBI fallen behind the curve? Why does raising interest rates not necessarily make groceries cheaper? And who holds the central bank accountable when it misses its inflation target?

    Host Anirban Chowdhury speaks to economist and Associate Professor of Economics, Indira Gandhi Institute of Development Research (IGIDR), Rajeswari Sengupta about the RBI's policy dilemmas, questionable inflation forecasts, contradictory interventions in financial markets, and the growing tension between inflation and economic growth. Most importantly, they examine why ordinary Indians deserve greater transparency from the institution tasked with protecting their purchasing power.

    See omnystudio.com/listener for privacy information.

    17 November 2026, 12:20 am
  • 26 minutes 12 seconds
    The AI Boom Hits a Political Wall. Can India Cash In?

    America voted blue. AI stocks bled red. And the world's biggest technology companies suddenly face a problem money alone cannot solve: public resistance. The US midterm elections have turned massive AI data centres into political battlegrounds, with voters protesting soaring electricity bills, water consumption and unchecked expansion. Could this derail America's AI ambitions and redirect billions in investment towards India? Or will China emerge stronger in the global AI race? Dia Rekhi speaks to Alex Tanenbaum, partner at Torys LLP about the political backlash threatening Silicon Valley's infrastructure boom, the risks confronting investors and India's opportunity to capitalise on the disruption.
    Credits
    Al Jazeera English
    CNN-News18
    India Today
    NBC News
    Our Rich Journey
    12 News
    Finance Stack
    Nick Bencino Finance
    Nick Bencino Markets

    See omnystudio.com/listener for privacy information.

    13 November 2026, 12:20 am
  • 27 minutes 26 seconds
    Liquid Biopsy: Catching Cancer Early With a Simple Blood Test

    In 2010, scientists Catherine Alix-Panabières and Klaus Pantel coined the term “liquid biopsy”, which Nature later named one of the key cancer discoveries of the last 20 years. Their blood-based approach can detect cancer early, spare patients painful needle biopsies, help doctors choose the right therapy and flag when a treatment stops working. Professor Pantel says a $1,000 test could save around $10,000 in ineffective treatment. In this conversation with The Economic Times pharma editor Vikas Dandekar, they explain why adoption is still slow, how India can take a bigger role in global clinical trials, and how immunotherapy and AI could shape the future of cancer care. Listen in

    See omnystudio.com/listener for privacy information.

    12 November 2026, 12:20 am
  • 32 minutes 39 seconds
    Why Youth Are Taking to the Streets: From Paris to Belgrade to India

     In this Morning Brief conversation, Dia Rekhi speaks with political scientist and and researcher at CERI, Sciences Po Paris Gilles Verniers about the wave of youth-led protests sweeping the globe. Starting with France’s student-led movement, they explore why young people anchor these uprisings, whether “Gen Z” is too simple a label, and how economic anxiety, shrinking opportunity and AI-driven job fears connect movements from Paris to Serbia to India’s Cockroach Janata Party. Vernier also discusses electoral conversion, why authenticity beats youth-speak in politics, how AI is reshaping campaigns, and why minority protests remain legitimate in a democracy. He closes by declining to predict where they lead.

    Listen In

    Check out other interesting episodes like - Cognizant’s Surya Gummadi on How AI Can Deliver Returns, The Future of Insurance in India | Sarbvir Singh of PB Fintech, Groww’s ₹6,600 Cr Leap - Fintech’s Big Market Test Begins , OML CEO on the Creator Economy’s Next Wave & much more.

    Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

    See omnystudio.com/listener for privacy information.

    10 November 2026, 12:20 am
  • 29 minutes 23 seconds
    OpenAI's India Bet: From ChatGPT Users to AI-Powered Businesses

    India has become ChatGPT’s largest market by weekly active users. But can OpenAI turn that extraordinary reach into a sustainable business? In this conversation with The Economic Times’ tech editor Surabhi Agarwal, OpenAI India Managing Director Prabhjeet Singh discusses the shift from AI experimentation to enterprise adoption, the challenge of monetising Indian users, and the company’s growing investments in local infrastructure. He also addresses competition from technology giants, the rise of autonomous AI agents, ChatGPT advertising, cybersecurity risks and India’s push for AI sovereignty. As AI valuations soar, can real-world adoption justify the enormous investments being made?

    Listen In

    You can follow Anirban Chowdhury on his social media: X and Linkedin

    Check out other interesting episodes like - Cognizant’s Surya Gummadi on How AI Can Deliver Returns, The Future of Insurance in India | Sarbvir Singh of PB Fintech, Groww’s ₹6,600 Cr Leap - Fintech’s Big Market Test Begins , OML CEO on the Creator Economy’s Next Wave & much more.

    Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

    See omnystudio.com/listener for privacy information.

    9 November 2026, 12:20 am
  • 19 minutes 19 seconds
    India's Banks Under Cyberattack: How AI Is Changing the Game

    India's rapidly expanding financial ecosystem faces a growing cybersecurity challenge. While large banks have invested heavily in protecting their systems, fintech companies and non-banking financial institutions remain vulnerable to increasingly sophisticated attacks. Artificial intelligence is changing the economics of cybercrime, allowing attackers to identify weaknesses faster, at significantly lower costs and on a much larger scale.

    Anirban Chowdhury speaks to Yash Kakadia, founder of Security Brigade, about how these attacks work, the vulnerabilities within financial technology infrastructure, the limitations of compliance-driven security, and whether India's regulators and financial institutions can keep pace with an accelerating threat.

    You can follow Anirban Chowdhury on his social media: X and Linkedin

    Check out other interesting episodes like: How Will a Volatile ₹ Impact You in 2026?, How Quick Commerce is Triggering a Health Crisis for Gen Z, Two Women Fought to Change India's Maternity Laws...and Succeeded, Can India Truly End Naxalism?, Semaglutide Goes Generic: Big Pharma’s Moat Breaks  and much more.

    Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

    See omnystudio.com/listener for privacy information.

    5 November 2026, 12:20 am
  • 18 minutes 47 seconds
    The Cancer Drug Price Trap

    Why does a cancer injection bought by a hospital for ₹11,000 end up costing a patient ₹1.3 lakh? India’s drug pricing system is under scrutiny as the government caps trade margins on hundreds of cancer medicines at 30%. While prices of several drugs have fallen sharply, nearly one in four packs has seen no reduction. And a 30% margin still allows a markup of nearly 43% over the manufacturer’s price. So who profits from expensive medicines? Why have previous interventions failed? And will the latest price cuts actually bring relief to patients? Anirban Chowdhury talks to ET's pharma editor Vikas Dandekar. Listen in:

    You can follow Anirban Chowdhury on his social media: X and Linkedin

    Check out other interesting episodes like: How Will a Volatile ₹ Impact You in 2026?, How Quick Commerce is Triggering a Health Crisis for Gen Z, Two Women Fought to Change India's Maternity Laws...and Succeeded, Can India Truly End Naxalism?, Semaglutide Goes Generic: Big Pharma’s Moat Breaks  and much more.

     

    Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

    See omnystudio.com/listener for privacy information.

    3 November 2026, 12:20 am
  • 36 minutes 15 seconds
    AI Agents Are Breaking the Internet’s Ad Model

    When AI agents book your flights, buy your groceries and pick your hotels, no one is scrolling, and no one sees an ad. So how does the internet make money?

    Lightspeed India partners Harsha Kumar and Hemanth Mohapatra explain which purchases agents will take over and which will stay human. They also cover why you can’t upsell an AI agent, what that means for the ad-based internet, and why India may prefer paying per outcome over subscriptions. They make the case for vertical AI built for tier-two and tier-three India, compare today’s AI wave with the dot-com era, and share how they use AI assistants themselves.

    Tune in.

    You can follow Himanshi Lohchab on her social media: X and Linkedin

     

    Check out other interesting episodes like: How Will a Volatile ₹ Impact You in 2026?, How Quick Commerce is Triggering a Health Crisis for Gen Z, Two Women Fought to Change India's Maternity Laws...and Succeeded, Can India Truly End Naxalism?, Semaglutide Goes Generic: Big Pharma’s Moat Breaks  and much more.

     

    Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

    See omnystudio.com/listener for privacy information.

    2 November 2026, 12:20 am
  • 22 minutes 44 seconds
    China vs US: The New War Over Cancer Drugs and Biotech Supremacy | The Morning Brief Decode

    China challenged America's dominance in manufacturing, technology and artificial intelligence. Now, it is threatening another American stronghold: the pharmaceutical industry.

    Chinese biotech companies are developing breakthrough drugs faster and cheaper than their American counterparts. One Chinese cancer drug, ivonescimab, is emerging as a potential challenger to Keytruda, Merck's $31-billion blockbuster. Meanwhile, Western pharmaceutical giants are striking multibillion-dollar licensing deals with Chinese innovators.

    But Washington is worried. Could America's growing dependence on Chinese biotechnology become a national security threat? And could India benefit from this escalating rivalry?

    In this episode of The Morning Brief Decode, Anirban Chowdhury speaks to The Economic Times' pharma editor Vikas Dandekar about China's biotech revolution, the battle for the future of medicine, the US response and India's opportunity to become a bigger player in global drug innovation.

    See omnystudio.com/listener for privacy information.

    30 October 2026, 12:20 am
  • 23 minutes 54 seconds
    Does Slumping Smartphone Demand Spell a Gloomy Diwali?

    India’s smartphone market is heading into Diwali on a sour note. Shipments fell sharply in the July–September quarter, with the sub-₹20,000 segment hit hardest. A global memory-chip crunch is raising costs, pushing up prices and forcing buyers to delay upgrades, settle for fewer features or choose refurbished phones. But does this slump signal a wider squeeze on household spending, or is it a supply shock tied to the race to build AI data centres? We examine what falling shipments reveal about affordability, consumption and India’s mobile growth, with Counterpoint Research’s Tarun Pathak and Bank of Baroda chief economist Madan Sabnavis.

    See omnystudio.com/listener for privacy information.

    29 October 2026, 12:20 am
  • More Episodes? Get the App